| 15.04 0.47 (3.23%) | 04-24 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 18.32 | 1-year : | 19.79 |
| Resists | First : | 15.69 | Second : | 16.95 |
| Pivot price | 14.83  |
|||
| Supports | First : | 13.65 | Second : | 11.36 |
| MAs | MA(5) : | 14.55  |
MA(20) : | 15.04 |
| MA(100) : | 14.8 |
MA(250) : | 16.8 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 45.1 |
D(3) : | 36.1 |
| RSI | RSI(14): 49.8 |
|||
| 52-week | High : | 26.11 | Low : | 9.69 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TCMD ] has closed below upper band by 40.4%. Bollinger Bands are 6.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 15.6 - 15.68 | 15.68 - 15.74 |
| Low: | 14.37 - 14.45 | 14.45 - 14.53 |
| Close: | 14.9 - 15.03 | 15.03 - 15.16 |
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Wed, 24 Apr 2024
Tactile Systems Technology and ESCO Technologies have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Wed, 24 Apr 2024
Bull Of The Day: Tactile Systems Technology (TCMD) - Yahoo Finance Australia
Tue, 23 Apr 2024
Wall Street Analysts See Tactile Systems Technology (TCMD) as a Buy: Should You Invest? - Yahoo Finance
Thu, 18 Apr 2024
Tactile Systems Technology (TCMD) Stock Moves -0.14%: What You Should Know - Yahoo Canada Finance
Wed, 17 Apr 2024
Is Tactile Systems Technology (TCMD) Stock Undervalued Right Now? - Yahoo Finance
Thu, 14 Mar 2024
Are Investors Undervaluing Tactile Systems Technology (TCMD) Right Now? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 24 (M) |
| Shares Float | 22 (M) |
| Held by Insiders | 1.4 (%) |
| Held by Institutions | 92.6 (%) |
| Shares Short | 1,180 (K) |
| Shares Short P.Month | 1,420 (K) |
| EPS | 1.23 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.19 |
| Profit Margin | 10.3 % |
| Operating Margin | 15.1 % |
| Return on Assets (ttm) | 3.6 % |
| Return on Equity (ttm) | 18.1 % |
| Qtrly Rev. Growth | 5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 11.54 |
| EBITDA (p.s.) | 0.93 |
| Qtrly Earnings Growth | 54.7 % |
| Operating Cash Flow | 36 (M) |
| Levered Free Cash Flow | 11 (M) |
| PE Ratio | 12.22 |
| PEG Ratio | 4.9 |
| Price to Book value | 1.83 |
| Price to Sales | 1.3 |
| Price to Cash Flow | 9.96 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|